Advertisement
Screener

NEUROCRINE BIOSCIENCES INC (NBIX) Graph

NBIX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $959.00M; Cost of revenue (m); Research and development (m); Selling, general and administrative $439.70M.
  • 2026-03-31: Revenue $814.50M; Cost of revenue $13.80M; Research and development (m); Selling, general and administrative $318.50M.
  • 2025-12-31: Revenue $805.50M*; Cost of revenue $17.60M*; Research and development (m); Selling, general and administrative $301.80M*.
  • 2025-09-30: Revenue $794.90M; Cost of revenue $14.00M; Research and development (m); Selling, general and administrative $291.60M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NBIX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$954.30MCollaboration Revenue$4.70MRevenue$959.00MOperating income$151.50MSelling, general& administrative$439.70MPre-tax income$162.20MIncome tax$17.80MNet income$144.40M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NBIX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$959.00MRevenue$959.00MOperating income$151.50MSelling, general& administrative$439.70MPre-tax income$162.20MIncome tax$17.80MNet income$144.40M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$959.00M(m)(m)$439.70M(m)$17.80M$144.40M
2026-03-31$814.50M$13.80M(m)$318.50M(m)$48.90M$197.90M
2025-12-31$805.50M*$17.60M*(m)$301.80M*(m)$85.70M*$153.70M*
2025-09-30$794.90M$14.00M(m)$291.60M(m)$82.30M$209.50M
2025-06-30$687.50M$11.30M(m)$286.30M(m)$52.00M$107.50M
2025-03-31$572.60M$9.20M(m)$276.50M(m)$6.80M$7.90M
2024-09-30$622.10M$8.00M(m)$234.30M(m)$60.50M$129.80M
2024-06-30$590.20M$9.20M(m)$242.00M(m)$33.60M$65.00M
2024-03-31$515.30M$7.50M(m)$243.10M(m)-$8.90M$43.40M
2023-09-30$498.80M$11.20M(m)$204.20M(m)$32.50M$83.10M
2023-06-30$452.70M$11.50M(m)$221.80M(m)$26.10M$95.50M
2023-03-31$420.40M$8.50M(m)$242.70M(m)-$26.70M-$76.60M
2022-09-30$387.90M$6.10M(m)$186.30M(m)$29.40M$68.50M
2022-06-30$378.20M$4.80M(m)$182.80M(m)-$6.40M-$16.90M
2022-03-31$310.60M$4.60M(m)$200.70M(m)$7.50M$13.90M
2021-09-30$296.00M$4.20M(m)$154.60M(m)$8.00M$22.50M
2021-06-30$288.90M$3.10M(m)$143.20M(m)$15.20M$42.30M
2021-03-31$236.60M$2.90M$73.20M$129.00M(m)-$4.90M$32.10M
2020-12-31$247.90M(m)(m)(m)$176.10M(m)$347.90M
2020-09-30$258.50M$2.70M(m)$112.50M$302.80M$500.00K-$57.60M
2020-06-30$302.40M$2.40M(m)$96.50M$225.80M$3.60M$79.60M
2020-03-31$237.10M$2.10M$58.30M$117.80M$178.20M$1.50M$37.40M
2019-12-31$244.10M(m)(m)(m)$195.30M(m)$34.00M
2019-09-30$222.10M$2.20M(m)$84.50M$132.00M$4.60M$53.80M
2019-06-30$183.50M$1.60M$61.69M$80.80M$149.10M$800.00K$51.30M
2019-03-31$138.40M$1.13M$37.65M$87.50M$239.40M-$500.00K-$102.10M
2018-12-31$131.49M$1.53M*$39.11M*(m)$109.62M(m)$18.08M
2018-09-30$151.76M$1.55M$35.48M$60.40M$97.43M(m)$50.76M
2018-06-30$96.91M$854.00K$36.99M$60.91M$98.76M(m)-$5.91M
2018-03-31$71.09M$950.00K$48.95M$58.64M$108.53M(m)-$41.82M
2017-12-31$94.52M(m)(m)(m)$82.68M(m)$6.89M
2017-09-30$60.77M$433.00K$22.46M$43.87M$66.77M(m)-$11.13M
2017-06-30$6.33M$61.00K$21.87M$41.67M$63.60M(m)-$59.98M
2017-03-31$0.00(m)$51.88M$28.05M$79.93M(m)-$78.33M
2016-12-31$0.00(m)(m)(m)$46.25M(m)-$44.66M
2016-09-30$0.00(m)$20.94M$17.49M$38.44M(m)-$36.89M
2016-06-30$0.00(m)$26.86M$14.96M$41.83M(m)-$40.28M
2016-03-31$15.00M(m)$23.90M(m)$35.86M(m)-$19.26M
2015-12-31$0.00(m)(m)(m)$30.75M(m)-$29.32M
2015-09-30$0.00(m)$24.39M(m)$35.84M(m)-$34.44M
2015-06-30$0.00(m)$18.72M(m)$25.32M(m)-$23.99M
2015-03-31$19.77M(m)$16.57M(m)$22.06M(m)-$1.19M
2014-12-31$0.00(m)(m)(m)$20.47M(m)-$19.44M
2014-09-30$0.00(m)$12.19M(m)$16.86M(m)-$15.88M
2014-06-30$0.00(m)$10.16M(m)$14.36M(m)-$13.38M
2014-03-31$0.00(m)$8.57M(m)$12.72M(m)-$11.84M
2013-12-31$730.00K(m)(m)(m)$12.26M(m)-$10.64M
2013-09-30$729.00K(m)$9.49M(m)$12.73M(m)-$11.13M
2013-06-30$730.00K(m)$10.53M(m)$13.90M(m)-$12.24M
2013-03-31$730.00K(m)$10.31M(m)$13.71M(m)-$12.07M
2012-12-31$21.95M(m)(m)(m)$13.37M(m)$9.49M
2012-09-30$9.36M(m)$9.86M(m)$13.32M(m)-$3.08M
2012-06-30$10.57M(m)$8.82M(m)$11.95M(m)-$501.00K
2012-03-31$11.27M(m)$9.39M(m)$13.06M(m)-$886.00K
2011-12-31$11.11M(m)(m)(m)$10.66M(m)$1.33M
2011-09-30$41.63M(m)$7.46M(m)$11.19M(m)$31.38M
2011-06-30$12.16M(m)$8.18M(m)$11.06M(m)$1.98M
2011-03-31$12.51M(m)$7.32M(m)$10.57M(m)$2.88M
2010-09-30$14.45M(m)$8.23M(m)$11.98M(m)$3.33M
2010-06-30$4.64M(m)$7.28M(m)$10.53M(m)-$5.15M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$1.77B(m)(m)$758.20M(m)$66.70M$342.30M
2025-06-30$1.26B$20.50M(m)$562.80M(m)$58.80M$115.40M
2024-06-30$1.11B$16.70M(m)$485.10M(m)$24.70M$108.40M
2023-06-30$873.10M$20.00M(m)$464.50M(m)-$600.00K$18.90M
2022-06-30$688.80M$9.40M(m)$383.50M(m)$1.10M-$3.00M
2021-06-30$525.50M$6.00M(m)$272.20M(m)$10.30M$74.40M
2020-06-30$539.50M$4.50M(m)$214.30M(m)$5.10M$117.00M
2019-06-30$321.90M$2.70M$99.34M$168.30M$388.52M$300.00K-$50.80M
2018-06-30$167.99M$1.80M$85.94M$119.55M$207.29M(m)-$47.73M
2017-06-30$6.33M$61.00K$73.75M$69.72M$143.53M(m)-$138.31M
2016-06-30$15.00M(m)$50.77M$26.92M$77.69M(m)-$59.54M
2015-06-30$19.77M(m)$35.29M(m)$47.38M(m)-$25.18M
2014-06-30$0.00(m)$18.73M(m)$27.09M(m)-$25.22M
2013-06-30$1.46M(m)$20.84M(m)$27.60M(m)-$24.32M
2012-06-30$21.84M(m)$18.21M(m)$25.01M(m)-$1.39M
2011-06-30$24.67M(m)$15.49M(m)$21.63M(m)$4.86M
2010-06-30$5.40M(m)$14.86M(m)$21.45M(m)-$13.79M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$2.06B$34.50M(m)$854.40M(m)$141.10M$324.90M
2024-09-30$1.73B$24.70M(m)$719.40M(m)$85.20M$238.20M
2023-09-30$1.37B$31.20M(m)$668.70M(m)$31.90M$102.00M
2022-09-30$1.08B$15.50M(m)$569.80M(m)$30.50M$65.50M
2021-09-30$821.50M$10.20M(m)$426.80M(m)$18.30M$96.90M
2020-09-30$798.00M$7.20M(m)$326.80M(m)$5.60M$59.40M
2019-09-30$544.00M$4.90M(m)$252.80M$520.51M$4.90M$3.00M
2018-09-30$319.75M$3.35M$121.42M$179.95M$304.72M(m)$3.03M
2017-09-30$67.11M$494.00K$96.21M$113.60M$210.30M(m)-$149.44M
2016-09-30$15.00M(m)$71.71M$44.41M$116.12M(m)-$96.43M
2015-09-30$19.77M(m)$59.68M(m)$83.22M(m)-$59.61M
2014-09-30$0.00(m)$30.93M(m)$43.94M(m)-$41.10M
2013-09-30$2.19M(m)$30.33M(m)$40.34M(m)-$35.45M
2012-09-30$31.19M(m)$28.07M(m)$38.33M(m)-$4.46M
2011-09-30$66.30M(m)$22.95M(m)$32.83M(m)$36.24M
2010-09-30$19.84M(m)$23.09M(m)$33.44M(m)-$10.46M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$2.86B$52.10M(m)$1.16B(m)$226.80M$478.60M
2024-12-31$2.36B$34.00M(m)$1.01B(m)$144.70M$341.30M
2023-12-31$1.89B$39.70M(m)$887.60M(m)$82.40M$249.70M
2022-12-31$1.49B$23.20M(m)$752.70M(m)$59.40M$154.50M
2021-12-31$1.13B$14.30M(m)$583.30M$1.03B$11.80M$89.60M
2020-12-31$1.05B$10.10M(m)$433.30M$882.90M-$300.60M$407.30M
2019-12-31$788.10M(m)(m)$354.10M$715.80M$9.50M$37.00M
2018-12-31$451.20M$4.89M$160.52M$248.90M$414.40M$700.00K$21.10M
2017-12-31$161.63M$1.25M$121.83M$169.91M$292.99M$0.00-$142.54M
2016-12-31$15.00M$0.00$94.29M$68.08M$162.37M$0.00-$141.09M
2015-12-31$19.77M(m)$81.49M$32.48M$113.97M$0.00-$88.93M
2014-12-31$0.00(m)$46.42M(m)$64.41M$0.00-$60.54M
2013-12-31$2.92M(m)$39.25M(m)$52.60M$0.00-$46.09M
2012-12-31$53.14M(m)$37.16M(m)$51.69M$0.00$5.03M
2011-12-31$77.41M(m)$30.95M(m)$43.49M$0.00$37.57M
2010-12-31$33.50M(m)$31.15M(m)$47.22M(m)-$7.97M
2009-12-31$2.95M(m)$33.72M(m)$56.62M(m)-$51.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXELIXIS, INC. (EXEL)United States$14.358B16.15
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78